title: Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice.
abstract: The human prolactin-inducible protein/gross cystic disease fluid protein-15 (PIP/GCDFP-15) gene is expressed in more than 90% of human breast cancer biopsies but not in the normal mammary gland. However, it is expressed in several normal human apocrine glands such as the lacrimal and salivary glands. In human breast cancer cell lines, the gene is regulated by a number of hormones including androgen and prolactin. It is not known whether gene expression in normal tissues is under similar hormonal control. To understand the mechanisms by which hormone- and tissue-specific expression of the human PIP/GCDFP-15 gene are regulated in vivo, we generated transgenic mice using a 13.7 kb genomic DNA fragment containing the entire 7 kb human gene, together with 2.9 kilobases of 5' and 3.8 kilobases of 3' flanking sequences. The human PIP/GCDFP-15 transgene was found to be expressed in both the lacrimal and salivary glands but was not expressed in the mammary glands of transgenic mice. This tissue-specific pattern of the transgene expression in the mouse was very similar to that of the endogenous human PIP/GCDFP-15 gene, and to the endogenous mouse,gene. In the mouse salivary glands, the transgene expression was highest in the parotid, considerably less in the submaxillary (submandibular) and absent in the sublingual glands. In the mouse lacrimal gland, as in the human breast cancer cell lines, the human PIP/GCDFP-15 transgene was also up-regulated by androgen. These studies demonstrate that the human gene with its 6.3 kb flanking sequences is able to confer gene expression in vivo in a tissue-specific and hormone-responsive manner.
authors.affiliation: Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
authors.forename: Y
authors.initials: Y
authors.lastname: Myal
authors.forename: B
authors.initials: B
authors.lastname: Iwasiow
authors.forename: H
authors.initials: H
authors.lastname: Cosby
authors.forename: A
authors.initials: A
authors.lastname: Yarmill
authors.forename: A
authors.initials: A
authors.lastname: Blanchard
authors.forename: D
authors.initials: D
authors.lastname: Tsuyuki
authors.forename: A
authors.initials: A
authors.lastname: Fresnoza
authors.forename: M L
authors.initials: ML
authors.lastname: Duckworth
authors.forename: R P
authors.initials: RP
authors.lastname: Shiu
mesh_terms: D000818:Animals; D001053:Apolipoproteins; D053399:Apolipoproteins D; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000502:physiology*; D006023:Glycoproteins; D006728:Hormones / Q000502:physiology*; D006801:Humans; D026901:Membrane Transport Proteins; D051379:Mice; D008822:Mice, Transgenic
chemical_list: C024328:APOD protein, human; D001053:Apolipoproteins; D053399:Apolipoproteins D; D002352:Carrier Proteins; D006023:Glycoproteins; D006728:Hormones; D026901:Membrane Transport Proteins; C488892:PIP protein, human